Evidence map›Paper›PMID 33352318›Full record

ArticleOphthalmology. Retina2021

Reticular Pseudodrusen in Late-Onset Retinal Degeneration.

Shyamanga Borooah, Vasileios Papastavrou, Leonardo Lando, Jonathan Han, Jonathan H Lin, Radha Ayyagari, Baljean Dhillon, Andrew C Browning

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in Ophthalmology. Retina, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Anterior segment phenotypic changes in late-onset retinal degeneration with Ser163Arg mutation in CTRP5/C1QTNF5.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2023
    Article
  7. Age-Related Macular or Retinal Degeneration?Medicina (Kaunas, Lithuania) · 2023
    Review
  8. Article
  9. Late-Onset Retinal Degeneration: Clinical Perspectives.Clinical ophthalmology (Auckland, N.Z.) · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Shyamanga BorooahCentre for Clinical Brain Sciences, School of Clinical Sciences, University of Edinburgh, Edinburgh, United Kingdom; Shiley Eye Institute, University of California, San Diego, La Jolla, California. Electronic address: sborooah@health.ucsd.edu.
Vasileios PapastavrouNewcastle Eye Centre, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom.
Leonardo LandoShiley Eye Institute, University of California, San Diego, La Jolla, California; Department of Ophthalmology, Federal University of Goias, Goiania, Brazil.
Jonathan HanShiley Eye Institute, University of California, San Diego, La Jolla, California.
Jonathan H LinShiley Eye Institute, University of California, San Diego, La Jolla, California; Departments of Ophthalmology and Pathology, Stanford University, Stanford, California; Veterans Affairs, Palo Alto Healthcare System, Palo Alto, California.
Radha AyyagariShiley Eye Institute, University of California, San Diego, La Jolla, California.
Baljean DhillonCentre for Clinical Brain Sciences, School of Clinical Sciences, University of Edinburgh, Edinburgh, United Kingdom.
Andrew C BrowningNewcastle Eye Centre, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom.
University of California San Diego · USRoyal Victoria Infirmary · GBUniversity of Edinburgh · GBVA Palo Alto Health Care System · US

Funding

Stanford Vision Research CoreP30EY026877 · NEI · STANFORD UNIVERSITY · PI Jeffrey L Goldberg · 2017 to 2026
$8.0M
Molecular Basis of Hereditary Retinal DegenerationsR01EY021237 · NEI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI AYYAGARI, RADHA · 2011 to 2020
$5.6M
Unraveling the molecular pathology of retinal degeneration through single cell genomicsR01EY031663 · NEI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI AYYAGARI, RADHA, FRAZER, KELLY A · 2021 to 2025
$3.3M
Molecular mechanism underlying late-onset retinal/macular degenerationR01EY030591 · NEI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI AYYAGARI, RADHA · 2020 to 2023
$1.9M
Molecular Pathology of AchromatopsiaR01EY027335 · NEI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LIN, JONATHAN · 2017 to 2019
$1.2M
BLRD VA I01 BX002284NEI NIH HHS P30 EY026877NEI NIH HHS R01 EY021237NEI NIH HHS R01 EY027335NEI NIH HHS R01 EY030591NEI NIH HHS R01 EY031663
6 · The paper itself

Abstract

purposeTo characterize the association of reticular pseudodrusen (RPD) with late-onset retinal degeneration (L-ORD) using multimodal imaging.

designProspective, 2-center, longitudinal case series.

participantsTwenty-nine patients with L-ORD.

methodsAll patients were evaluated within a 3-year interval with near-infrared reflectance, fundus autofluorescence, and spectral-domain OCT. In addition, a subset of patients also underwent indocyanine green angiography, fundus fluorescein angiography, mesopic microperimetry, and multifocal electroretinography.

main outcome measuresPrevalence, topographic distribution, and temporal phenotypic changes of RPD in L-ORD.

resultsA total of 29 patients with molecularly confirmed L-ORD were included in this prospective study. Reticular pseudodrusen was detected in 18 patients (62%) at baseline, 10 of whom were men. The prevalence of RPD varied with age. The mean age of RPD patients was 57.3 ± 7.2 years. Reticular pseudodrusen was not seen in patients younger than the fifth decade of life (n = 3 patients) or in the eighth decade of life (n = 5 patients). Reticular pseudodrusen were found commonly in the macula with relative sparing of the fovea and also were identified in the peripheral retina. The morphologic features of RPD changed with follow-up. Two patients (3 eyes) demonstrated RPD regression.

conclusionsReticular pseudodrusen is found frequently in patients with L-ORD and at a younger age than in individuals with age-related macular degeneration (AMD). Reticular pseudodrusen exhibits quick formation and collapse, change in type and morphologic features with time, and relative foveal sparing and also has a peripheral retinal location in L-ORD.

Indexed as

AdultAgedAged, 80 and overColoring AgentsElectroretinographyFemaleFluorescein AngiographyFollow-Up StudiesHumansIndocyanine GreenMaleMiddle AgedMultimodal ImagingProspective StudiesRetinal DegenerationRetinal DrusenColoring AgentsIndocyanine GreenMacular degenerationRetinaRetinal degenerationRetinal dystrophy

Identifiers

PMID33352318
PMCPMC8217414
OpenAlexW3116875807

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.